1. Home
  2. ODV vs RIGL Comparison

ODV vs RIGL Comparison

Compare ODV & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODV
  • RIGL
  • Stock Information
  • Founded
  • ODV 2005
  • RIGL 1996
  • Country
  • ODV Canada
  • RIGL United States
  • Employees
  • ODV N/A
  • RIGL N/A
  • Industry
  • ODV Precious Metals
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODV Basic Materials
  • RIGL Health Care
  • Exchange
  • ODV Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • ODV 338.9M
  • RIGL 335.5M
  • IPO Year
  • ODV N/A
  • RIGL 2000
  • Fundamental
  • Price
  • ODV $2.72
  • RIGL $38.85
  • Analyst Decision
  • ODV
  • RIGL Buy
  • Analyst Count
  • ODV 0
  • RIGL 5
  • Target Price
  • ODV N/A
  • RIGL $38.20
  • AVG Volume (30 Days)
  • ODV 1.1M
  • RIGL 995.6K
  • Earning Date
  • ODV 08-12-2025
  • RIGL 08-05-2025
  • Dividend Yield
  • ODV N/A
  • RIGL N/A
  • EPS Growth
  • ODV N/A
  • RIGL N/A
  • EPS
  • ODV N/A
  • RIGL 5.43
  • Revenue
  • ODV $5,147,156.00
  • RIGL $267,921,000.00
  • Revenue This Year
  • ODV $381.12
  • RIGL $59.93
  • Revenue Next Year
  • ODV $256.81
  • RIGL N/A
  • P/E Ratio
  • ODV N/A
  • RIGL $7.15
  • Revenue Growth
  • ODV N/A
  • RIGL 105.62
  • 52 Week Low
  • ODV $1.16
  • RIGL $12.66
  • 52 Week High
  • ODV $2.91
  • RIGL $43.72
  • Technical
  • Relative Strength Index (RSI)
  • ODV 60.30
  • RIGL 68.57
  • Support Level
  • ODV $2.43
  • RIGL $39.00
  • Resistance Level
  • ODV $2.91
  • RIGL $42.08
  • Average True Range (ATR)
  • ODV 0.14
  • RIGL 2.32
  • MACD
  • ODV 0.02
  • RIGL -0.37
  • Stochastic Oscillator
  • ODV 64.08
  • RIGL 53.26

About ODV Osisko Development Corp.

Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: